A Dose Escalation Study of Bradanicline in Refractory Chronic Cough
Clinical trial NCT03622216 · COMPLETED
Trial details
- NCT number
- NCT03622216
- Sponsor
- Attenua, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-05
- Primary completion
- 2019-05-07
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.